Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study

Life Effectiveness ◽

Once Daily

Real‐life effectiveness of once‐daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52‐week PRO ‐long study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.13230 ◽

2015 ◽

Vol 29 (12) ◽

pp. 2349-2355 ◽

Cited By ~ 19

Author(s):

J. Lambert ◽

C.W. Hol ◽

J. Vink

Keyword(s):

Psoriasis Vulgaris ◽

Real Life ◽

Final Analysis ◽

Life Effectiveness ◽

Once Daily

Abstract #203 The Real Life Effectiveness; Metabolic Effects and Tolerability of Hydroxychloroquine Once Daily in the Treatment of Type-2 Diabetes Mellitus

Endocrine Practice ◽

10.1016/s1530-891x(20)47049-1 ◽

2018 ◽

Vol 24 ◽

pp. 28-29

Author(s):

Hemant Thacker ◽

Rupal Shrimanker ◽

Banshi Saboo ◽

Diabetologist ◽

Anuj Maheshwari ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Real Life ◽

Metabolic Effects ◽

Life Effectiveness ◽

Once Daily ◽

The Real

A highly effective once daily treatment with a new two-compound calcipotriene/betamethasone dipropionate ointment in psoriasis vulgaris

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.10.501 ◽

2004 ◽

Vol 50 (3) ◽

pp. P144

Author(s):

Knud Kragballe ◽

Kirsten Noerrelund

Keyword(s):

Psoriasis Vulgaris ◽

Daily Treatment ◽

Once Daily ◽

Highly Effective

Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris

British Journal of Dermatology ◽

10.1111/j.1365-2133.2004.05986.x ◽

2004 ◽

Vol 150 (6) ◽

pp. 1167-1173 ◽

Cited By ~ 68

Author(s):

K. Kragballe ◽

K.L. Noerrelund ◽

H. Lui ◽

J.P. Ortonne ◽

G. Wozel ◽

...

Keyword(s):

Psoriasis Vulgaris ◽

Daily Treatment ◽

Once Daily ◽

Treatment Regimens ◽

Cost-Effectiveness of Once-Daily Treatment with Calcipotriol/Betamethasone Dipropionate Followed by Calcipotriol Alone Compared with Tacalcitol in the Treatment of Psoriasis vulgaris

Dermatology ◽

10.1159/000086444 ◽

2005 ◽

Vol 211 (2) ◽

pp. 139-145 ◽

Cited By ~ 22

Author(s):

Pascale Peeters ◽

Jean-Paul Ortonne ◽

René Sitbon ◽

Eric Guignard

Keyword(s):

Cost Effectiveness ◽

Psoriasis Vulgaris ◽

Daily Treatment ◽

Once Daily ◽

A New Calcipotriol/Betamethasone Dipropionate Formulation (DaivobetTM) Is an Effective Once-Daily Treatment for Psoriasis vulgaris

Dermatology ◽

10.1159/000066440 ◽

2002 ◽

Vol 205 (4) ◽

pp. 389-393 ◽

Cited By ~ 118

Author(s):

R. Kaufmann ◽

A.J. Bibby ◽

R. Bissonnette ◽

F. Cambazard ◽

A.C. Chu ◽

...

Keyword(s):

Psoriasis Vulgaris ◽

Daily Treatment ◽

Once Daily ◽

Psoriasis and skin pain: real‐life effectiveness of calcipotriol plus betamethasone dipropionate in aerosol foam formulation

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.15488 ◽

2019 ◽

Vol 33 (7) ◽

pp. 1312-1315 ◽

Cited By ~ 7

Author(s):

L. Gallo ◽

M. Megna ◽

T. Cirillo ◽

P. Caterino ◽

G. Lodi ◽

...

Keyword(s):

Real Life ◽

Life Effectiveness ◽

Foam Formulation ◽

Skin Pain

Calcipotriol/betamethasone dipropionate aerosol foam in the treatment of psoriasis: new perspectives for the use of an innovative topical treatment from real-life experience

Giornale Italiano di Dermatologia e Venereologia ◽

10.23736/s0392-0488.20.06492-5 ◽

2020 ◽

Vol 155 (2) ◽

Author(s):

Gabriella Fabbrocini ◽

Esteban Dauden ◽

Ahmad Jalili ◽

Anthony Bewley

Keyword(s):

Topical Treatment ◽

Life Experience ◽

Real Life ◽

PSS9 Cost-per-Responder (CPR) of Fixed Combination Calcipotriol PLUS Betamethasone Dipropionate CAL/BD Cutaneous FOAM VS. CAL/BD GEL in Patients with Mild to Moderate Psoriasis vulgaris

Value in Health ◽

10.1016/j.jval.2020.08.1971 ◽

2020 ◽

Vol 23 ◽

pp. S734

Author(s):

N. Bithal ◽

F. Oluwa ◽

J.R. Treloggen

Keyword(s):

Psoriasis Vulgaris ◽

Fixed Combination ◽

Cost Per Responder

Myelodysplastic syndromes: from conductiong clinical trials of novel therapies to evaluating real-life effectiveness of exisiting therapies

International Journal of Hematologic Oncology ◽

10.2217/ijh.15.25 ◽

2015 ◽

Vol 4 (6) ◽

pp. 215-217

Author(s):

Amer M Zeidan

Keyword(s):

Clinical Trials ◽

Myelodysplastic Syndromes ◽

Real Life ◽

Novel Therapies ◽

Life Effectiveness